{"id":2140,"date":"2007-10-02T18:49:07","date_gmt":"2007-10-02T17:49:07","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=2140"},"modified":"2013-09-12T16:14:32","modified_gmt":"2013-09-12T16:14:32","slug":"paediatric-formulation-of-fosamprenavir-approved-in-europe","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/2140","title":{"rendered":"Paediatric formulation of fosamprenavir approved in Europe"},"content":{"rendered":"<p><strong>On 13 September, the EMEA issued a decision to extend the indication for fosamprenavir (Telzir) in combination with ritonavir to include adolescents and children of six years and older.<\/strong><\/p>\n<p>Telzir &#8211; EMEA European Public Assessment Report (includes full prescribing information)<br \/>\n<a href=\"http:\/\/www.emea.europa.eu\/humandocs\/Humans\/EPAR\/telzir\/telzir.htm\">http:\/\/www.emea.europa.eu\/humandocs\/Humans\/EPAR\/telzir\/telzir.htm <\/a><br \/>\nTelzir &#8211; EMEA scientific opinion for approval PDF<br \/>\n<a href=\"http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/telzir\/EMEA-H-534-II-18-AR.pdf\">http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/telzir\/EMEA-H-534-II-18-AR.pdf<\/a><\/p>\n<p>Source: GSK press release.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 13 September, the EMEA issued a decision to extend the indication for fosamprenavir (Telzir) in combination with ritonavir to include adolescents and children of six years and older. Telzir &#8211; EMEA European Public Assessment Report (includes full prescribing information) &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2140","post","type-post","status-publish","format-standard","hentry","category-antiretrovirals"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=2140"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2140\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=2140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=2140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=2140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}